image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 16.67
0.604 %
$ 3.32 B
Market Cap
-3.73
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one XRAY stock under the worst case scenario is HIDDEN Compared to the current market price of 16.7 USD, DENTSPLY SIRONA Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one XRAY stock under the base case scenario is HIDDEN Compared to the current market price of 16.7 USD, DENTSPLY SIRONA Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one XRAY stock under the best case scenario is HIDDEN Compared to the current market price of 16.7 USD, DENTSPLY SIRONA Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart XRAY

image
$20.0$20.0$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.015 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '25
FINANCIALS
3.79 B REVENUE
-4.34%
-879 M OPERATING INCOME
-934.12%
-910 M NET INCOME
-589.39%
461 M OPERATING CASH FLOW
22.28%
-197 M INVESTING CASH FLOW
-121.35%
-302 M FINANCING CASH FLOW
1.63%
879 M REVENUE
-2.87%
63 M OPERATING INCOME
112.38%
19 M NET INCOME
104.42%
7 M OPERATING CASH FLOW
-91.95%
-17 M INVESTING CASH FLOW
70.18%
123 M FINANCING CASH FLOW
423.68%
Balance Sheet DENTSPLY SIRONA Inc.
image
Current Assets 1.75 B
Cash & Short-Term Investments 272 M
Receivables 606 M
Other Current Assets 868 M
Non-Current Assets 4.01 B
Long-Term Investments 0
PP&E 902 M
Other Non-Current Assets 3.1 B
4.73 %10.53 %15.09 %15.68 %53.97 %Total Assets$5.8b
Current Liabilities 1.59 B
Accounts Payable 241 M
Short-Term Debt 595 M
Other Current Liabilities 753 M
Non-Current Liabilities 2.22 B
Long-Term Debt 1.68 B
Other Non-Current Liabilities 544 M
6.33 %15.62 %19.76 %44.02 %14.28 %Total Liabilities$3.8b
EFFICIENCY
Earnings Waterfall DENTSPLY SIRONA Inc.
image
Revenue 3.79 B
Cost Of Revenue 1.84 B
Gross Profit 1.96 B
Operating Expenses 2.84 B
Operating Income -879 M
Other Expenses 31 M
Net Income -910 M
4b4b4b4b3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)(1b)(1b)4b(2b)2b(3b)(879m)(31m)(910m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
51.62% GROSS MARGIN
51.62%
-23.17% OPERATING MARGIN
-23.17%
-23.99% NET MARGIN
-23.99%
-46.86% ROE
-46.86%
-15.82% ROA
-15.82%
-17.96% ROIC
-17.96%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DENTSPLY SIRONA Inc.
image
600m600m500m500m400m400m300m300m200m200m100m100m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -910 M
Depreciation & Amortization 349 M
Capital Expenditures -180 M
Stock-Based Compensation 39 M
Change in Working Capital 95 M
Others 1.03 B
Free Cash Flow 281 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DENTSPLY SIRONA Inc.
image
Wall Street analysts predict an average 1-year price target for XRAY of $22.4 , with forecasts ranging from a low of $14 to a high of $31 .
XRAY Lowest Price Target Wall Street Target
14 USD -16.02%
XRAY Average Price Target Wall Street Target
22.4 USD 34.37%
XRAY Highest Price Target Wall Street Target
31 USD 85.96%
Price
Max Price Target
Min Price Target
Average Price Target
32323030282826262424222220201818161614141212Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
1.08% DIVIDEND YIELD
0.16 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
0.70000.70000.60000.60000.50000.50000.40000.40000.30000.30000.20000.20000.10000.10000.00000.00000.0720.07750.08750.08750.08750.10.10.1250.140.160.160.07250.07750.08750.08750.08750.10.110.1250.140.160.160.07250.07750.08750.08750.10.10.110.1250.140.160.07250.290.07750.310.08750.350.08750.350.10.380.10.400.110.430.1250.500.140.560.160.640.322015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership DENTSPLY SIRONA Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
250 K USD 1
3-6 MONTHS
421 K USD 2
6-9 MONTHS
200 K USD 1
9-12 MONTHS
7. News
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 5 days ago
XRAY or MMSI: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Dentsply International (XRAY) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 6 days ago
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 6 days ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 3 weeks ago
XRAY vs. MMSI: Which Stock Is the Better Value Option? Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 3 weeks ago
Should Value Investors Buy Dentsply Sirona (XRAY) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 3 weeks ago
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 3 weeks ago
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 3 weeks ago
Is the Options Market Predicting a Spike in Dentsply Sirona Stock? Investors need to pay close attention to XRAY stock based on the movements in the options market lately. zacks.com - 3 weeks ago
Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now XRAY continues to gain traction from a robust product portfolio. However, the macroeconomic factors, such as weakened global demand, persist. zacks.com - 3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 4 weeks ago
INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Dentsply Sirona Inc. (NASDAQ:XRAY) ("Dentsply") on behalf of the company's long-term investors. Click here to receive additional information about your legal rights and options: https://kaskelalaw.com/case/dentsply-sirona/ Recently an amended securities fraud complaint was filed against Dentsply on behalf of investors who purchased shares of the company's stock between June 9, 2021 and November 13, 2022. accessnewswire.com - 4 weeks ago
8. Profile Summary

DENTSPLY SIRONA Inc. XRAY

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 3.32 B
Dividend Yield 1.08%
Description DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Contact 13320 Ballantyne Corporate Place, Charlotte, NC, 28277-3607 https://www.dentsplysirona.com
IPO Date Aug. 12, 1987
Employees 14000
Officers Mr. Simon D. Campion Chief Executive Officer, President & Director Mr. Herman V. Cueto Interim Chief Financial Officer Mr. Kevin Boyle Senior Vice President & Chief Technology Officer Mr. David Ferguson Senior Vice President of Global Business Unit Leader Mr. Richard C. Rosenzweig J.D. Executive Vice President of Corporate Development, General Counsel & Secretary Mr. Robert Anthony Johnson Senior Vice President & Chief Supply Chain Officer and Head of Sustainability Ms. Andrea L. Frohning Senior Vice President & Chief Human Resources Officer Ms. Andrea Daley Vice President of Investor Relations Mr. Kevin J. Czerney Vice President & Chief Accounting Officer Ms. Emily P. Miner Senior Vice President of Global Quality and Regulatory & Chief Quality Officer